Literature DB >> 29637219

[Community-acquired pneumonia].

M Hecker1, N Sommer2, K Tello2, A Hecker3, W Seeger2, K Mayer2.   

Abstract

Community-acquired pneumonia (CAP) is a frequent and potentially fatal disorder. Due to the notably high mortality within the first days, the immediate initiation of rational diagnostic pathways and treatment is of tremendous prognostic impact. In this review article, the current German guideline on the diagnosis and therapy of CAP is presented. Special focus is put on structured patient management based on the individual risk for early identification of critically ill patients. In particular, risk assessment directly influences rational diagnostics and adequate therapy. New recommendations concerning preventive strategies are also discussed in this article.

Entities:  

Keywords:  Antibiotics; Bronchopneumonia; Influenza; Pneumococcal infection; Risk factors

Mesh:

Substances:

Year:  2018        PMID: 29637219     DOI: 10.1007/s00063-018-0426-x

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  25 in total

1.  Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.

Authors:  O Burkhardt; S Ewig; U Haagen; S Giersdorf; O Hartmann; K Wegscheider; E Hummers-Pradier; T Welte
Journal:  Eur Respir J       Date:  2010-02-25       Impact factor: 16.671

2.  Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events.

Authors:  Roberto Cangemi; Camilla Calvieri; Marco Falcone; Tommaso Bucci; Giuliano Bertazzoni; Maria G Scarpellini; Francesco Barillà; Gloria Taliani; Francesco Violi
Journal:  Am J Cardiol       Date:  2015-05-22       Impact factor: 2.778

3.  Community-Acquired Pneumonia in Adults.

Authors:  Martin Kolditz; Santiago Ewig
Journal:  Dtsch Arztebl Int       Date:  2017-12-08       Impact factor: 5.594

4.  Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.

Authors:  Vicente F Corrales-Medina; Daniel M Musher; George A Wells; Julio A Chirinos; Li Chen; Michael J Fine
Journal:  Circulation       Date:  2012-01-04       Impact factor: 29.690

5.  [Management of Adult Community-acquired Pneumonia and Prevention - Update 2016].

Authors:  S Ewig; G Höffken; W V Kern; G Rohde; H Flick; R Krause; S Ott; T Bauer; K Dalhoff; S Gatermann; M Kolditz; S Krüger; J Lorenz; M Pletz; A de Roux; B Schaaf; T Schaberg; H Schütte; T Welte
Journal:  Pneumologie       Date:  2016-02-29

6.  Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study.

Authors:  Santiago Ewig; Benjamin Klapdor; Mathias W Pletz; Gernot Rohde; Hartwig Schütte; Tom Schaberg; Torsten T Bauer; Tobias Welte
Journal:  Thorax       Date:  2011-11-05       Impact factor: 9.139

Review 7.  Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.

Authors:  James D Chalmers; Pallavi Mandal; Aran Singanayagam; Ahsan R Akram; Gourab Choudhury; Philip M Short; Adam T Hill
Journal:  Intensive Care Med       Date:  2011-06-10       Impact factor: 17.440

8.  Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Authors:  Sandra S Richter; Daniel J Diekema; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

9.  Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial.

Authors:  Fahrettin Oz; Sule Gul; Mehmet G Kaya; Mehmet Yazici; Ismet Bulut; Ali Elitok; Gunay Ersin; Ozlem Abakay; Cayan D Akkoyun; Aytac Oncul; Erdogan Cetinkaya; Michael C Gibson; Huseyin Oflaz
Journal:  Coron Artery Dis       Date:  2013-05       Impact factor: 1.439

10.  New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.

Authors:  S Ewig; N Birkner; R Strauss; E Schaefer; J Pauletzki; H Bischoff; P Schraeder; T Welte; G Hoeffken
Journal:  Thorax       Date:  2009-05-18       Impact factor: 9.139

View more
  2 in total

1.  [Hospital-acquired pneumonia].

Authors:  K Tello; M J Richter; W Seeger; M Hecker
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-10-09       Impact factor: 0.840

2.  [Evolution of CT manifestations in a Coronavirus (2019-nCoV) pneumonia patient].

Authors:  Qianna Jin; Claus Peter Heußel; Hans-Ulrich Kauczor; Wei Cui; Guoyi Lv
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-05-04       Impact factor: 0.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.